ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

GLPG Galapagos NV

25,44
0,00 (0,00%)
17 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Galapagos NV GLPG NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 25,44 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
25,44
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
14.6.202422:01GLOBEGalapagos presents encouraging new data for CD19 CAR-T..
30.5.202422:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30.5.202422:01GLOBEGalapagos and Adaptimmune sign clinical collaboration..
16.5.202422:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16.5.202422:01GLOBEGalapagos creates new subscription right plans
16.5.202414:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15.5.202422:01GLOBEGalapagos and Blood Centers of America announce strategic..
02.5.202422:01GLOBEGalapagos reports first quarter 2024 financial results  
30.4.202422:01GLOBEGalapagos’ shareholders adopt all resolutions proposed by..
04.4.202422:01GLOBEGalapagos showcases innovative approach in hematological..
28.3.202421:01GLOBEGalapagos publishes 2023 annual report and announces Annual..
26.3.202421:01GLOBEGalapagos appoints Andrew Dickinson as Non-Executive..
23.2.202412:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22.2.202422:01GLOBEFrontier Medicines Announces Oversubscribed $80 Million..
16.2.202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15.2.202422:01GLOBEGalapagos presents at EBMT-EHA annual meeting 2024
14.2.202423:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31.1.202422:01GLOBEGalapagos completes transaction to transfer Jyseleca®..
04.1.202422:44DJNGalapagos, Thermo Fisher to Collaborate on Expanding..
04.1.202422:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04.1.202422:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04.1.202422:01GLOBEGalapagos enters into strategic collaboration agreement with..
03.1.202422:01PRNUSBridGene Biosciences Announces Strategic Collaboration with..
02.1.202407:00GLOBEGalapagos signs agreement to transfer Jyseleca® business to..
21.12.202322:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19.12.202322:01GLOBEGalapagos announces start of PAPILIO-1 Phase 1/2 multiple..
09.12.202318:00GLOBEGalapagos presents new encouraging data at ASH 2023 from..
07.12.202322:01GLOBEGalapagos to Host KOL Event on December 10, 2023, at 11:00..
06.11.202313:45PRNUSLandmark Bio Signs Multi-Year Agreement to Manufacture..
03.11.202313:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02.11.202321:01GLOBEGalapagos reports third quarter 2023 results and releases..
02.11.202312:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30.10.202321:01GLOBEGalapagos concludes strategic evaluation and signs letter of..
19.9.202322:01GLOBEGalapagos appoints Simon Sturge to its Board of Directors
28.8.202322:01GLOBEGalapagos announces start of Phase 2 study with selective..
04.8.202322:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03.8.202322:01GLOBEGalapagos announces first half-year 2023 financial results

Kürzlich von Ihnen besucht

Delayed Upgrade Clock